2 completed, 1 recruiting. 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow saruplase: new trials by email Literature Review of saruplase trials Research Report on saruplase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase prourokinase - Acute Ischemic Stroke | Phase 2 | Recruiting | General Hospital of Shenyang Military Region | 122 | 2026-05-06 | 2026-06-30 |
| Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Prourokinase, Tirofiban, normal saline - Myocardial Infarction, Percutaneous Coronary Intervention | Phase 4 | Completed | Fudan University | 362 | 2015-11-01 | 2018-08-07 |
| Pharmacoinvasive Therapy With Prourokinase Prourokinase, Placebo - ST-segment Elevation Myocardial Infarction (STEMI) | Phase 2 / Phase 3 | Completed | Suzhou Landing Pharmaceuticals | 197 | 2008-11-01 | 2012-07-27 |
Ischemic Stroke (1) · Myocardial Infarction (1) · No-Reflow Phenomenon (1) · ST Elevation Myocardial Infarction (1)
Fudan University (1) · General Hospital of Shenyang Military Region (1) · Suzhou Landing Pharmaceuticals (1)
China (3)
Junbo Ge, M.D. (1)